| Literature DB >> 21191479 |
Krunoslav T Stingl1, Stephanie Kullmann, Martina Guthoff, Martin Heni, Andreas Fritsche, Hubert Preissl.
Abstract
Lean and obese subjects can exhibit differences in neuronal activity during resting state and tasks. Changes in hormonal status and their action related to increased body weight may be the determining factor for these differences. One prime candidate is insulin, which until recently was mainly related to its metabolic function for the transport and regulation of glucose in the periphery. However insulin also acts as an anorexic signal in the central nervous system contributing to the termination of food intake in the postprandial state. In our study, we examined with whole-head magnetoencephalography the effect of intranasal insulin on the dynamics of the resting state network in a placebo controlled study. Weighted clustering coefficient C, which describes local interconnectedness, and weighted path length L, a measure of global interconnectedness, were computed. These parameters showed high intraindividual reliability. However, no difference for the network dynamics was found between lean and obese subjects in the basal state. The application of insulin led to subject specific changes and we found a statistically significant positive correlation between the insulin induced change in path length in the theta band (4-8 Hz) and body mass index. The change in pathway length after insulin administration indicates a strong insulin modulation on global communication efficiency, which is probably related to the signaling between different regions involved in satiation and homeostatic control.Entities:
Keywords: brain dynamics; insulin; magnetoencephalography; obesity; resting state
Year: 2010 PMID: 21191479 PMCID: PMC3010825 DOI: 10.3389/fnsys.2010.00157
Source DB: PubMed Journal: Front Syst Neurosci ISSN: 1662-5137
Subject characteristics.
| Lean subjects | Obese subjects | |
|---|---|---|
| 10 (7/3) | 10 (7/3) | |
| Age (years) | 25.7 ± 1.5 | 26.7 ± 1.8 |
| BMI (kg/m2) | 20.9 ± 0.4 | 28.8 ± 0.6 |
| HbA1c (%) | 5.4 ± 0.1 | 5.5 ± 0.1 |
All data are given as mean ± SEM.
Metabolic parameters during MEG experiment (insulin or placebo spray was given at time = 0 min).
| Time (min) | |||||||
|---|---|---|---|---|---|---|---|
| −30 | 0 | 30 | 60 | ||||
| Placebo | Lean subjects | Glucose (mmol/l) | 4.7 ± 0.1 | 4.7 ± 0.1 | 4.4 ± 0.1 | 4.4 ± 0.1 | 0.31 |
| Insulin | 4.6 ± 0.1 | 4.8 ± 0.1 | 4.6 ± 0.1 | 4.6 ± 0.1 | |||
| Placebo | Obese subjects | 5.1 ± 0.1 | 5.3 ± 0.2 | 5.0 ± 0.1 | 5.1 ± 0.2 | 0.76 | |
| Insulin | 5.1 ± 0.1 | 5.3 ± 0.2 | 5.0 ± 0.1 | 5.1 ± 0.1 | |||
| Placebo | Lean subjects | Insulin (pmol/l) | 39 ± 5.6 | 33 ± 5.5 | 33 ± 4.8 | 32 ± 6.8 | 0.42 |
| Insulin | 34 ± 3.9 | 33 ± 5.1 | 41 ± 5.8 | 34 ± 4.8 | |||
| Placebo | Obese subjects | 59 ± 10.3 | 61 ± 11.8 | 70 ± 15.9 | 65 ± 12.1 | 0.23 | |
| Insulin | 68 ± 11.9 | 62 ± 11.4 | 88 ± 15.5 | 66 ± 9.1 | |||
| Placebo | Lean subjects | C-peptide (pmol/l) | 360 ± 36 | 379 ± 53 | 345 ± 36 | 372 ± 51 | 0.19 |
| Insulin | 336 ± 34 | 336 ± 39 | 314 ± 38 | 289 ± 29 | |||
| Placebo | Obese subjects | 520 ± 53 | 554 ± 69 | 535 ± 66 | 555 ± 67 | 0.07 | |
| Insulin | 609 ± 52 | 584 ± 62 | 595 ± 82 | 544 ± 68 | |||
All data are given as mean ± SEM. Statistical test between insulin and placebo condition was performed using MANOVA analysis. The p-value time × insulin/placebo shows differences in the curves over time of insulin and placebo.
Figure 1Bar plot of reliability measurements by inter intra class correlation (ICC, calculated for mixed model, type consistency and averaged measures) for different frequency ranges for normalized cluster coefficient (C) and normalized path length (L, *.
Figure 2Bar plot showing the mean values of (A) cluster coefficient (B) path length of the two baseline measurements for the lean and obese group. All data are given as mean ± SEM, *p < 0.05.
Figure 3Bar plot showing the (A) insulin induced change in the cluster coefficient in the lean and obese group (B) insulin induced change in the path length in the lean and obese group. All data are given as mean ± SEM, *p < 0.05.
Figure 4Scatter plot showing the correlation between BMI and difference between the coefficient of path length in theta band (difference between basal measurement and after administration of the insulin corrected for the placebo measurement) for all subjects.